Literature DB >> 22092077

Interchromosomal effect analyses by sperm FISH: incidence and distribution among reorganization carriers.

Ester Anton1, Francesca Vidal, Joan Blanco.   

Abstract

Structural reorganization carriers usually present compromised fertility accompanied by an increased risk of producing gametes with chromosomal abnormalities that can be transmitted to the offspring. In part these imbalances are ascribed to result from the occurrence of meiotic disturbances produced by the rearrangements in the proper segregation of other chromosome pairs. This phenomenon of interference has been called interchromosomal effect (ICE). Several studies have been performed to assess the occurrence of ICE in structural reorganization carriers by analyzing the frequencies of numerical abnormalities in the gametes. Nevertheless, the occurrence and distribution of these disturbing events still is a controversial issue. In this work we present compiled data from 130 sperm fluorescent in situ hybridization (FISH) studies performed in carriers of the most frequent structural rearrangements in humans: 44 Robertsonian translocations, 66 reciprocal translocations and 13 inversions. Data from 7 complex/multiple rearrangements will be considered in a separate group. Significant increases of gametes with numerical abnormalities have been detected in all types of reorganization carriers. Among the groups of non-complex/multiple rearrangements, Robertsonian translocations appear to be the most prone to produce such interference (54.5%) closely followed by reciprocal translocations (43.9%). In contrast, ICE's were only detected in 7.7% of the inversion carriers analyzed. The presence of complex/multiple rearrangements seems to be an important factor for promoting ICE, as 71.4% of these carriers presented increased rates of gametes with numerical abnormalities. Altogether, almost half of the structural reorganization carriers (45.4%) present a higher reproductive risk of producing aneuploid/diploid spermatozoa compared to the general population. This high incidence has been obtained by analyzing a small set of chromosomes, suggesting that underlying meiotic disorders could be present in these individuals. Further ICE studies in structural reorganization carriers will help to clarify the still unknown predisposing cytogenetic features that promote this phenomenon.

Entities:  

Mesh:

Year:  2011        PMID: 22092077     DOI: 10.3109/19396368.2011.633682

Source DB:  PubMed          Journal:  Syst Biol Reprod Med        ISSN: 1939-6368            Impact factor:   3.061


  12 in total

1.  Interchromosomal effect in carriers of translocations and inversions assessed by preimplantation genetic testing for structural rearrangements (PGT-SR).

Authors:  E Mateu-Brull; L Rodrigo; V Peinado; A Mercader; I Campos-Galindo; F Bronet; S García-Herrero; M Florensa; M Milán; C Rubio
Journal:  J Assist Reprod Genet       Date:  2019-11-06       Impact factor: 3.412

2.  Preliminary analysis of numerical chromosome abnormalities in reciprocal and Robertsonian translocation preimplantation genetic diagnosis cases with 24-chromosomal analysis with an aCGH/SNP microarray.

Authors:  Yanxin Xie; Yanwen Xu; Jing Wang; Benyu Miao; Yanhong Zeng; Chenhui Ding; Jun Gao; Canquan Zhou
Journal:  J Assist Reprod Genet       Date:  2017-09-18       Impact factor: 3.412

3.  Infertility patients with chromosome inversions are not susceptible to an inter-chromosomal effect.

Authors:  D Young; D Klepacka; M McGarvey; W B Schoolcraft; M G Katz-Jaffe
Journal:  J Assist Reprod Genet       Date:  2018-12-15       Impact factor: 3.412

4.  Sperm meiotic segregation, aneuploidy and high risk of delivering an affected offspring in carriers of non-Robertsonian translocation t(13;15).

Authors:  Katerina Kasikova; Miluse Vozdova; Petra Prinosilova; Renata Gaillyova; Marta Hanakova; Jiri Rubes
Journal:  J Assist Reprod Genet       Date:  2012-04-21       Impact factor: 3.412

5.  Logistic regression analyses of factors affecting the euploidy of blastocysts undergoing in vitro fertilization and preimplantation genetic testing.

Authors:  Zhiping Zhang; Lei Zhang; Yaoqin Wang; Xingyu Bi; Lixia Liang; Yuan Yuan; Dan Su; Xueqing Wu
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

6.  Balanced chromosomal translocations in men: relationships among semen parameters, chromatin integrity, sperm meiotic segregation and aneuploidy.

Authors:  Miluse Vozdova; Eva Oracova; Katerina Kasikova; Petra Prinosilova; Roman Rybar; Vera Horinova; Renata Gaillyova; Jiri Rubes
Journal:  J Assist Reprod Genet       Date:  2013-01-15       Impact factor: 3.412

7.  Investigation of the interchromosomal effects in male carriers with structural chromosomal abnormalities using FISH.

Authors:  Özgür Balasar; Hasan Acar
Journal:  Turk J Urol       Date:  2020-03-14

8.  Meiotic pairing and gene expression disturbance in germ cells from an infertile boar with a balanced reciprocal autosome-autosome translocation.

Authors:  Harmonie Barasc; Annabelle Congras; Nicolas Mary; Lidwine Trouilh; Valentine Marquet; Stéphane Ferchaud; Isabelle Raymond-Letron; Anne Calgaro; Anne-Marie Loustau-Dudez; Nathalie Mouney-Bonnet; Hervé Acloque; Alain Ducos; Alain Pinton
Journal:  Chromosome Res       Date:  2016-08-02       Impact factor: 5.239

9.  The tumor suppressor BRCA1-BARD1 complex localizes to the synaptonemal complex and regulates recombination under meiotic dysfunction in Caenorhabditis elegans.

Authors:  Qianyan Li; Takamune T Saito; Marina Martinez-Garcia; Alison J Deshong; Saravanapriah Nadarajan; Katherine S Lawrence; Paula M Checchi; Monica P Colaiacovo; JoAnne Engebrecht
Journal:  PLoS Genet       Date:  2018-11-01       Impact factor: 5.917

10.  Chromosome (re)positioning in spermatozoa of fathers and sons - carriers of reciprocal chromosome translocation (RCT).

Authors:  Marta Olszewska; Ewa Wiland; Nataliya Huleyuk; Monika Fraczek; Alina T Midro; Danuta Zastavna; Maciej Kurpisz
Journal:  BMC Med Genomics       Date:  2019-02-01       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.